Compounds > ertapenem
Page last updated: 2024-09-04

ertapenem and Infection, Pelvic

ertapenem has been researched along with Infection, Pelvic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Citron, DM; Goldstein, EJ; Motyl, M; Pelak, BA; Teppler, H; Woods, GL1
Gesser, R; McCarroll, K; Tellado, J; Teppler, H; Woods, GL1
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL1
Adeyi, B; Angel-Muller, E; Hague, C; Higareda, I; Ismail, M; Roy, S; Teppler, H; Woods, GL1
Gesser, RM; Graham, DR; Meibohm, AR; Roy, S; Solomkin, J; Teppler, H; Woods, GL1

Trials

4 trial(s) available for ertapenem and Infection, Pelvic

ArticleYear
Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections.
    Surgical infections, 2002,Winter, Volume: 3, Issue:4

    Topics: Abdomen; Adult; Aged; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection

2002
Surgical infections with enterococcus: outcome in patients treated with ertapenem versus piperacillin-tazobactam.
    Surgical infections, 2002,Winter, Volume: 3, Issue:4

    Topics: Abdomen; Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Enterococcus; Ertapenem; Female; Gram-Positive Bacterial Infections; Humans; Lactams; Male; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Surgical Wound Infection; Treatment Outcome

2002
Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study.
    Infectious diseases in obstetrics and gynecology, 2003, Volume: 11, Issue:1

    Topics: Acute Disease; Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Confidence Intervals; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Ertapenem; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Lactams; Middle Aged; Pelvic Infection; Penicillanic Acid; Piperacillin; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome

2003
Treatment of polymicrobial infections: post hoc analysis of three trials comparing ertapenem and piperacillin-tazobactam.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2

    Topics: Abdomen; Adolescent; Adult; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Double-Blind Method; Ertapenem; Female; Humans; Lactams; Male; Pelvic Infection; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Skin Diseases, Bacterial; Treatment Outcome

2004

Other Studies

1 other study(ies) available for ertapenem and Infection, Pelvic

ArticleYear
Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection.
    The Journal of antimicrobial chemotherapy, 2002, Volume: 50, Issue:5

    Topics: Acute Disease; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ertapenem; Humans; Lactams; Microbial Sensitivity Tests; Pelvic Infection

2002